
HDFC Pharma and Healthcare Fund - Direct Plan - IDCW Option
HDFC Mutual Fund · Sectoral/Thematic · Direct · IDCW
NAV · as of 11/09/2026
22.71
1D
-0.44%1Y
+27.47%Key stats
- Expense ratio
- 1.11%
- AUM
- ₹2.94 K Cr
- Launched
- 04/10/2023
- Fund manager
- Dhruv Muchhal; Nikhil Mathur
- Portfolio turnover
- 0.37%
- Risk
- Very High Risk
- Min lump-sum
- ₹100
- Min SIP
- ₹100/mo
- Fresh lump-sum
- Accepted
- Fresh SIP
- Accepted
NAV history
HDFC Pharma and Healthcare Fund - Direct Plan - IDCW Option
13/08/2026 to 11/09/2026
O - H - L -
Top holdings
38 disclosed- 1.9.96%
Sun Pharmaceuticals Industries Ltd
Healthcare
- 2.7.16%
Divi's Laboratories Ltd
Healthcare
- 3.5.57%
Max Healthcare Institute Ltd Ordinary Shares
Healthcare
- 4.5.26%
Lupin Ltd
Healthcare
- 5.5.19%
Cipla Ltd
Healthcare
- 6.5.05%
Aster DM Quality Care Ltd Ordinary Shares
Healthcare
- 7.4.58%
Acutaas Chemicals Ltd
Basic Materials
- 8.4.00%
Alkem Laboratories Ltd
Healthcare
- 9.3.81%
Anthem Biosciences Ltd
Healthcare
- 10.3.53%
Ipca Laboratories Ltd
Healthcare
- 11.3.32%
Treps - Tri-Party Repo
- 12.3.18%
Fortis Healthcare Ltd
Healthcare
- 13.3.08%
Global Health Ltd
Healthcare
- 14.3.07%
Krishna Institute of Medical Sciences Ltd
Healthcare
- 15.2.93%
Neuland Laboratories Ltd
Healthcare
- 16.2.88%
Glenmark Pharmaceuticals Ltd
Healthcare
- 17.2.53%
Vijaya Diagnostic Centre Ltd
Healthcare
- 18.2.48%
Shilpa Medicare Ltd
Healthcare
- 19.2.34%
Zydus Lifesciences Ltd
Healthcare
- 20.2.24%
Metropolis Healthcare Ltd
Healthcare
- 21.2.11%
Wockhardt Ltd
Healthcare
- 22.1.71%
Sai Life Sciences Ltd
Healthcare
- 23.1.70%
Rubicon Research Ltd
Healthcare
- 24.1.51%
Thyrocare Technologies Ltd
Healthcare
- 25.1.49%
Eris Lifesciences Ltd Registered Shs
Healthcare
- 26.1.42%
Ajanta Pharma Ltd
Healthcare
- 27.1.31%
Corona Remedies Ltd
Healthcare
- 28.1.20%
Gland Pharma Ltd
Healthcare
- 29.1.18%
Jubilant Pharmova Ltd
Healthcare
- 30.1.17%
Biocon Ltd
Healthcare
- 31.1.04%
Dr Reddy's Laboratories Ltd
Healthcare
- 32.0.77%
Bajaj Healthcare Ltd
Healthcare
- 33.0.56%
Laxmi Dental Ltd
Healthcare
- 34.0.54%
Net Current Assets
- 35.0.53%
Novartis India Ltd
Healthcare
- 36.0.44%
Cohance Lifesciences Ltd
Healthcare
- 37.0.27%
Jupiter Life Line Hospitals Ltd
Healthcare
- 38.-
Laurus Labs Ltd
Sector allocation
- Healthcare92.65%
- Basic Materials4.58%
- Unclassified3.86%
Comparable peers
HDFC Pharma & Healthcare IDCW Reinvest Direct Plan
HDFC Pharma & Healthcare IDCW Reinvest (DR) · ₹2.94 K Cr AUM
1Y+28.30%3Y0.00%-SBI Healthcare Opportunities IDCW Payout Direct Plan
SBI Healthcare Opportunities IDCW Payout (DP) · ₹5.40 K Cr AUM
1Y+22.46%3Y+24.66%-HDFC Transportation & Logistics IDCW Reinvest Direct Plan
HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM
1Y+9.29%3Y+25.53%-HDFC Transportation & Logistics IDCW Payout Direct Plan
HDFC Transportation & Logistics IDCW Payout (DP) · ₹1.96 K Cr AUM
1Y+9.29%3Y+25.53%-HDFC Transportation & Logistics IDCW Reinvest Direct Plan
HDFC Transportation & Logistics IDCW Reinvest (DR) · ₹1.96 K Cr AUM
1Y+9.29%3Y+25.53%-
Investment objective
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
Scheme details
- Scheme code
- 152081
- Fund house
- HDFC Mutual Fund
- Category
- Open Ended
- Type
- Equity Scheme
- Sub-category
- Sectoral/Thematic
- Plan
- Direct
- Return type
- IDCW
- ISIN (Growth)
- INF179KC1HP8
- ISIN (Div. Reinvest)
- INF179KC1HQ6
- Tradable on exchange
- No